One month after launching the national COVID-19 vaccination campaign in Gabon, less than 17 per cent of the priority persons have so far appeared for vaccination, the government said.
According to the country’s Ministry of Health, medical personnel, security forces agents, aged persons, and persons suffering from health complications were targeted to receive the first doses of the Sinopharm vaccine in Estuaire and Ogooue-Maritime provinces.
However, “only 17 per cent of these priority persons have demonstrated their confidence in the Chinese vaccine,” a senior health official in Libreville informed HumAngle on Thursday.
At the launch of the campaign, government officials aimed at vaccinating at least 500,000 people, with about 13,659 being priority targets.
“We are very far from obtaining this goal. In fact, as of April 24, 2021, these priority persons represent less than 17 per cent of those vaccinated,” a health official who opted for anonymity revealed.
“In effect, within the three provinces where vaccination has been going on, very few persons have voluntarily presented themselves to be vaccinated with the first dose of the Sinopharm vaccine.”
The government is already contemplating strategies to use in persuading at least 90 per cent of persons in the targeted groups to go for vaccinations.
At most vaccination centres, even the health personnel themselves are not very eager to take the vaccine though the government still hopes that the situation would change in the not very distant future.
Support Our Journalism
There are millions of ordinary people affected by conflict in Africa whose stories are missing in the mainstream media. HumAngle is determined to tell those challenging and under-reported stories, hoping that the people impacted by these conflicts will find the safety and security they deserve.
To ensure that we continue to provide public service coverage, we have a small favour to ask you. We want you to be part of our journalistic endeavour by contributing a token to us.
Your donation will further promote a robust, free, and independent media.Donate Here